<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="brief-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Ann Lab Med</journal-id>
      <journal-id journal-id-type="iso-abbrev">Ann Lab Med</journal-id>
      <journal-id journal-id-type="publisher-id">ALM</journal-id>
      <journal-title-group>
        <journal-title>Annals of Laboratory Medicine</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">2234-3806</issn>
      <issn pub-type="epub">2234-3814</issn>
      <publisher>
        <publisher-name>The Korean Society for Laboratory Medicine</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">27139615</article-id>
      <article-id pub-id-type="pmc">4855062</article-id>
      <article-id pub-id-type="doi">10.3343/alm.2016.36.4.380</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Letter to the Editor</subject>
          <subj-group subj-group-type="subheading">
            <subject>Diagnostic Hematology</subject>
          </subj-group>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>First Case of Diffuse Large B-Cell Lymphoma Subtype of Monomorphic Post-Transplant Lymphoproliferative Disorder With 3q27 Translocation</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>Hyerim</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Kim</surname>
            <given-names>In-Suk</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lee</surname>
            <given-names>Eun Yup</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Shin</surname>
            <given-names>Dong Hoon</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cho</surname>
            <given-names>Su-Hee</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A4">4</xref>
        </contrib>
      </contrib-group>
      <aff id="A1"><label>1</label>Department of Laboratory Medicine, Biomedical Research Institute, Pusan National University Hospital, Busan, Korea.</aff>
      <aff id="A2"><label>2</label>Department of Laboratory Medicine, Pusan National University Yangsan Hospital, Yangsan, Korea.</aff>
      <aff id="A3"><label>3</label>Department of Pathology, Pusan National University Yangsan Hospital, Yangsan, Korea.</aff>
      <aff id="A4"><label>4</label>Division of Hematology-Oncology, Department of Internal Medicine, Pusan National University Yangsan Hospital, Yangsan, Korea.</aff>
      <author-notes>
        <corresp>Corresponding author: In-Suk Kim. Department of Laboratory Medicine, Pusan National University Yangsan Hospital, 20 Geumo-ro, Mulgeum-eup, Yangsan 50612, Korea. Tel: +82-55-360-1878, Fax: +82-55-360-1880, <email>iskim0710@gmail.com</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>7</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>25</day>
        <month>4</month>
        <year>2016</year>
      </pub-date>
      <volume>36</volume>
      <issue>4</issue>
      <fpage>380</fpage>
      <lpage>383</lpage>
      <history>
        <date date-type="received">
          <day>04</day>
          <month>9</month>
          <year>2015</year>
        </date>
        <date date-type="rev-recd">
          <day>14</day>
          <month>12</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>12</day>
          <month>2</month>
          <year>2016</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; The Korean Society for Laboratory Medicine.</copyright-statement>
        <copyright-year>2016</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
    </article-meta>
  </front>
  <body>
    <p>Dear Editor,</p>
    <p>Post-transplant lymphoproliferative disorders (PTLDs) are a rare group of atypical lymphoid proliferations that develop as a result of immunosuppression in recipients of solid organ transplant or allogeneic hematopoietic stem cell transplant. According to the 4th edition of the World Health Organization Classification of Tumors of Haematopoietic and Lymphoid Tissues, PTLD is further divided into four categories on the basis of the histologic, immunophenotypic, and genetic characteristics: (1) early lesions consisting of plasmacytic hyperplasia and infectious mononucleosis&#x2013;like, (2) polymorphic PTLD, (3) monomorphic PTLD, further classified according to the respective lymphoid or plasmacytic neoplasm they resemble in immunocompetent individuals, and (4) classic Hodgkin lymphoma-type PTLD [<xref rid="B1" ref-type="bibr">1</xref>]. The diagnosis and classification of PTLD are currently based on histologic criteria; hence, cytogenetic abnormalities have not been fully investigated. We report the first case of a monomorphic PTLD, diffuse large B-cell lymphoma (DLBCL) infiltrating spleen and bone marrow (BM) with t(3;6)(q27;p22) involving <italic>BCL6</italic>.</p>
    <p>A 45-yr-old woman with a history of hepatocellular carcinoma secondary to hepatitis B virus (HBV)-associated liver cirrhosis, who underwent living donor liver transplantation four years ago, visited our hospital with severe anemia and dizziness. Her hemoglobin level was 5.8 g/dL. Abdominal computed tomography (CT) scans showed splenomegaly and multiple intra-abdominal lymph node enlargements. Spleen biopsy revealed proliferation of large, oval cells with abundant cytoplasm (<xref ref-type="fig" rid="F1">Fig. 1</xref>). In the immunohistochemical (IHC) examination, these atypical cells were positive for CD20, BCL-2, and MUM-1 and negative for CD10, CD3, CD5, cyclin D1, and BCL-6. The result of <italic>in situ</italic> hybridization with Epstein Barr virus (EBV)-encoded small RNA (EBER) was negative; however, real-time quantitative PCR of peripheral blood sample showed 2,820 EBV copies/mL.</p>
    <p>BM biopsy revealed the proliferation of large neoplastic B-cells that were positive for CD20 and negative for CD3 (<xref ref-type="fig" rid="F1">Fig. 1</xref>). Final diagnosis was monomorphic PTLD, DLBCL subtype. Chromosomal analysis of the BM specimen revealed 46,XX,t(3;6)(q27;p22),del(14)(q31)[17]/46,XX[3] (<xref ref-type="fig" rid="F2">Fig. 2</xref>). FISH analyses using dual-color <italic>IGH</italic> and <italic>BCL6</italic> (3q27) break-apart probes (Abbott Molecular Inc., Des Plaines, IL, USA) revealed <italic>BCL6</italic> rearrangements (22.5%) and heterozygous loss of 14q32 (9.7%) (<xref ref-type="fig" rid="F2">Fig. 2</xref>).</p>
    <p>The patient was treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP). Complete remission was achieved after six cycles of R-CHOP. After 14 months, brain magnetic resonance imaging demonstrated two lobulated enhancing masses at the posterior aspect of the medulla and nodulus of vermis, suggesting central nervous system (CNS) lymphoma. The cytospin of cerebrospinal fluid revealed slightly increased cell counts (18/&#xB5;L) and a few large lymphoid cells, suggestive of malignant lymphoma cells. Positron emission tomography-CT revealed marked hypermetabolic lesions on cerebellar vermis, consistent with lymphoma involvement. The patient was treated with five cycles of rituximab, methotrexate, vincristine, and procarbazine for the treatment of CNS lymphoma and achieved complete remission.</p>
    <p>Among 18 clonal abnormalities in monomorphic B-cell PTLD, rearrangements of 8q24.1 (4 cases), 3q27 (2 cases), 14q32 (2 cases), and trisomy 9, 11, or both (5 cases) have been reported [<xref rid="B2" ref-type="bibr">2</xref>]. Two PTLDs with 3q27 abnormalities showing DLBCL morphology have also been reported [<xref rid="B2" ref-type="bibr">2</xref>]. <italic>BCL6</italic> has been implicated in DLBCL, and <italic>BCL6</italic> rearrangements have been found in as many as 40% of DLBCLs and in 10% of a subset of follicular lymphoma. <italic>BCL6</italic> rearrangement is therefore one of the most frequent genetic abnormalities in B-cell non-Hodgkin's lymphomas (NHLs) [<xref rid="B3" ref-type="bibr">3</xref>]. The t(3;6)(q27;p22) has been reported in six cases of B-cell NHLs, and four of these cases have been described as DLBCL [<xref rid="B4" ref-type="bibr">4</xref><xref rid="B5" ref-type="bibr">5</xref><xref rid="B6" ref-type="bibr">6</xref><xref rid="B7" ref-type="bibr">7</xref>]. However, the clinical implication of t(3;6)(q27;p22) in B-cell NHLs has not been elucidated. Furthermore, PTLDs with t(3;6)(q27;p22) have never been reported.</p>
    <p>The 3q27/<italic>BCL6</italic> translocation is unique as it involves not only immunoglobulin genes but also non-immunoglobulin chromosomal loci as a partner. A comparative study suggested that non-immunoglobulin, <italic>BCL6</italic> translocation and concordant low <italic>BCL6</italic> mRNA expression are indicators of poor clinical outcome in DLBCL cases [<xref rid="B8" ref-type="bibr">8</xref>].</p>
    <p>Clinically, cases with CNS involvement show lower patient survival rate than those without CNS involvement [<xref rid="B9" ref-type="bibr">9</xref><xref rid="B10" ref-type="bibr">10</xref>]. Therefore, pathogenetic and clinical implications, including effects of CNS involvement, prognosis, and treatment, of monomorphic PTLD, DLBCL subtype with 3q27 abnormality require further investigations.</p>
    <p>To the best of our knowledge, this is the first report on monomorphic PTLD, DLBCL subtype with t(3;6)(q27;p22). The t(3;6)(q27;p22) might play a role in the pathogenesis and clinical outcome of this disease.</p>
  </body>
  <back>
    <fn-group>
      <fn fn-type="conflict">
        <p><bold>Authors' Disclosures of Potential Conflicts of Interest:</bold> No potential conflicts of interest relevant to this article were reported.</p>
      </fn>
    </fn-group>
    <ref-list>
      <ref id="B1">
        <label>1</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Swerdlow</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Weber</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Chadburn</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ferry</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <chapter-title>Post-transplant lymphoproliferative disorders</chapter-title>
          <person-group person-group-type="editor">
            <name>
              <surname>Campo</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Swerdlow</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Harris</surname>
              <given-names>NL</given-names>
            </name>
            <name>
              <surname>Pileri</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Stein</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Jaffe</surname>
              <given-names>ES</given-names>
            </name>
          </person-group>
          <source>WHO classification of tumours of haematopoietic and lymphoid tissues</source>
          <edition>4th ed</edition>
          <publisher-loc>Lyon</publisher-loc>
          <publisher-name>IARC</publisher-name>
          <year>2008</year>
          <fpage>8</fpage>
          <lpage>350</lpage>
        </element-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Djokic</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Le Beau</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Swinnen</surname>
              <given-names>LJ</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Rubin</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Anastasi</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Post-transplant lymphoproliferative disorder subtypes correlate with different recurring chromosomal abnormalities</article-title>
          <source>Genes Chromosomes Cancer</source>
          <year>2006</year>
          <volume>45</volume>
          <fpage>313</fpage>
          <lpage>318</lpage>
          <pub-id pub-id-type="pmid">16283619</pub-id>
        </element-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lo Coco</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Ye</surname>
              <given-names>BH</given-names>
            </name>
            <name>
              <surname>Lista</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Corradini</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Offit</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Knowles</surname>
              <given-names>DM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Rearrangements of the BCL6 gene in diffuse large cell non-Hodgkin's lymphoma</article-title>
          <source>Blood</source>
          <year>1994</year>
          <volume>83</volume>
          <fpage>1757</fpage>
          <lpage>1759</lpage>
          <pub-id pub-id-type="pmid">8142643</pub-id>
        </element-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Akasaka</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Miura</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Takahashi</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Akasaka</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Yonetani</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Ohno</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A recurring translocation, t(3;6)(q27;p21), in non-Hodgkin's lymphoma results in replacement of the 5' regulatory region of BCL6 with a novel H4 histone gene</article-title>
          <source>Cancer Res</source>
          <year>1997</year>
          <volume>57</volume>
          <fpage>7</fpage>
          <lpage>12</lpage>
          <pub-id pub-id-type="pmid">8988030</pub-id>
        </element-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Akasaka</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Akasaka</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Kurata</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ueda</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Shimizu</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Uchiyama</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Molecular anatomy of BCL6 translocations revealed by long-distance polymerase chain reaction-based assays</article-title>
          <source>Cancer Res</source>
          <year>2000</year>
          <volume>60</volume>
          <fpage>2335</fpage>
          <lpage>2341</lpage>
          <pub-id pub-id-type="pmid">10811103</pub-id>
        </element-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kurata</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Maesako</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Ueda</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Nishikori</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Akasaka</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Uchiyama</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Characterization of t(3;6)(q27;p21) breakpoints in B-cell non-Hodgkin's lymphoma and construction of the histone H4/BCL6 fusion gene, leading to altered expression of Bcl-6</article-title>
          <source>Cancer Res</source>
          <year>2002</year>
          <volume>62</volume>
          <fpage>6224</fpage>
          <lpage>6230</lpage>
          <pub-id pub-id-type="pmid">12414651</pub-id>
        </element-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schwindt</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Akasaka</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Z&#xFC;hlke-Jenisch</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Hans</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Schaller</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Klapper</surname>
              <given-names>W</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Chromosomal translocations fusing the BCL6 gene to different partner loci are recurrent in primary central nervous system lymphoma and may be associated with aberrant somatic hypermutation or defective class switch recombination</article-title>
          <source>J Neuropathol Exp Neurol</source>
          <year>2006</year>
          <volume>65</volume>
          <fpage>776</fpage>
          <lpage>782</lpage>
          <pub-id pub-id-type="pmid">16896311</pub-id>
        </element-citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lossos</surname>
              <given-names>IS</given-names>
            </name>
            <name>
              <surname>Jones</surname>
              <given-names>CD</given-names>
            </name>
            <name>
              <surname>Warnke</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Natkunam</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Kaizer</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Zehnder</surname>
              <given-names>JL</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Expression of a single gene, BCL-6, strongly predicts survival in patients with diffuse large B-cell lymphoma</article-title>
          <source>Blood</source>
          <year>2001</year>
          <volume>98</volume>
          <fpage>945</fpage>
          <lpage>951</lpage>
          <pub-id pub-id-type="pmid">11493437</pub-id>
        </element-citation>
      </ref>
      <ref id="B9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Evens</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Roy</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Sterrenberg</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Moll</surname>
              <given-names>MZ</given-names>
            </name>
            <name>
              <surname>Chadburn</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Gordon</surname>
              <given-names>LI</given-names>
            </name>
          </person-group>
          <article-title>Post-transplantation lymphoproliferative disorders: diagnosis, prognosis, and current approaches to therapy</article-title>
          <source>Curr Oncol Rep</source>
          <year>2010</year>
          <volume>12</volume>
          <fpage>383</fpage>
          <lpage>394</lpage>
          <pub-id pub-id-type="pmid">20963522</pub-id>
        </element-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cavaliere</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Petroni</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Lopes</surname>
              <given-names>MB</given-names>
            </name>
            <name>
              <surname>Schiff</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <collab>International Primary Central Nervous System Lymphoma Collaborative Group</collab>
          <article-title>Primary central nervous system post-transplantation lymphoproliferative disorder: an international primary central nervous system lymphoma collaborative group report</article-title>
          <source>Cancer</source>
          <year>2010</year>
          <volume>116</volume>
          <fpage>863</fpage>
          <lpage>870</lpage>
          <pub-id pub-id-type="pmid">20052713</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="F1" orientation="portrait" position="float">
      <label>Fig. 1</label>
      <caption>
        <title>Histopathologic findings of a monomorphic post-transplant lymphoproliferative disorder, diffuse large B-cell lymphoma subtype involving spleen (A, B, and C) and bone marrow (D, E, and F). (A) Hematoxylin and Eosin stain, &#xD7;40. (B) CD20 stain, &#xD7;40. (C) CD3 stain, &#xD7;40. (D) Hematoxylin and Eosin stain, &#xD7;100. (E) CD20 stain, &#xD7;100. (F) CD3 stain, &#xD7;100.</title>
      </caption>
      <graphic xlink:href="alm-36-380-g001"/>
    </fig>
    <fig id="F2" orientation="portrait" position="float">
      <label>Fig. 2</label>
      <caption>
        <title>Karyotype analysis of bone marrow specimen showing t(3;6)(q27;p22) and del(14)(q31) (A) and FISH results showing <italic>BCL6</italic> (3q27) rearrangement and loss of <italic>IGH</italic> (14q32) signals using dual-color, and break-apart probes, respectively (B and C).</title>
      </caption>
      <graphic xlink:href="alm-36-380-g002"/>
    </fig>
  </floats-group>
</article>
</pmc-articleset>
